Citizens National Bank Trust Department Has $7.67 Million Stock Position in Procter & Gamble Company (The) $PG

Citizens National Bank Trust Department reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 1.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,149 shares of the company’s stock after selling 553 shares during the quarter. Procter & Gamble accounts for approximately 1.5% of Citizens National Bank Trust Department’s holdings, making the stock its 19th biggest position. Citizens National Bank Trust Department’s holdings in Procter & Gamble were worth $7,671,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of PG. Kingstone Capital Partners Texas LLC increased its position in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC bought a new stake in Procter & Gamble in the 1st quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD raised its stake in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC boosted its position in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after acquiring an additional 1,674,139 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the firm’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

PG has been the subject of a number of analyst reports. BNP Paribas Exane cut their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. BNP Paribas restated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $173.11.

Read Our Latest Research Report on PG

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $152.60 on Wednesday. The stock has a 50-day simple moving average of $155.30 and a 200 day simple moving average of $159.79. The stock has a market capitalization of $357.16 billion, a price-to-earnings ratio of 23.44, a P/E/G ratio of 4.13 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter last year, the company posted $1.40 EPS. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.